Results 241 to 250 of about 390,927 (295)

A dialectical lens for AI and medical humanities: advancing responsible augmented humanism in Digital Public Health. [PDF]

Front Public Health
Chen S, Peng Z, Liu N.
europepmc   +1 more source

Clinician's attitudes & perspective on chemical adherence testing in hypertension (CATCH): A qualitative interview study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Chemical Adherence Testing (CAT) is gaining prominence as a reliable and valid clinical method to detect whether antihypertensive agents are being taken as prescribed. This study aimed to explore clinicians' attitudes and perspectives on the clinical use of CAT.
Roshan Shahab, Louise Rabbitt, Gerard J. Molloy   +2 more
wiley   +1 more source

Equitable inclusion of people with disabilities in clinical trials: a scoping review. [PDF]

BMJ Open
Jo G, Castro F, Cerilli C, Varadaraj V, Rosman L, Kamenov K, Barrett D, Swenor B.   +7 more
europepmc   +1 more source

A comparative study to determine a suitable representational data model for UK building regulations [PDF]

, 2013
Kumar, Bimal, McGibbney, Lewis
core  

Pharmacokinetic‐pharmacodynamic modelling of risankizumab using chronic plaque psoriasis real‐world data

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim Risankizumab is a high‐cost biologic treatment for chronic plaque psoriasis, an immune‐mediated inflammatory disease presenting with painful red scaly skin lesions. Inter‐individual heterogeneity in treatment response may be better addressed with personalised rather than fixed dosing. We sought to develop a pharmacokinetic/pharmacodynamic (
Charlotte M. Thomas, Jessica Ruoheng Wei, David Baudry, Zehra Arkir, Bola Coker, Tejus Dasandi, Kingsley Powell, Monica Arenas‐Hernandez, Jenny Leung, Krystal Rawstron, Chioma Nwaogu, Richard Woolf, Andrew E. Pink, Jonathan Barker, Joseph F. Standing, Catherine H. Smith, Satveer K. Mahil   +16 more
wiley   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Informed Consent in Shoulder and Elbow Surgery. [PDF]

Cureus
Sadh P, Almeda-Lopez A, Hershfeld B, Monessa D, Klein B, Cohn RM, Bitterman AD.   +6 more
europepmc   +1 more source

Open science must include effective results dissemination to study participants. [PDF]

PLoS Med
Tai KH, Legoff G, Le Louarn A, Munung NS, Naudet F.   +4 more
europepmc   +1 more source

Pretesting Parenting Instruments with Indigenous Fathers and Two-Spirit Parents: A Qualitative Study. [PDF]

Can J Nurs Res
Ferron EM, Butt ML, Goodfellow N, Dame J, George SD, VanEvery R, Wright AL.   +6 more
europepmc   +1 more source

Artificial intelligence in breast cancer: applications and advancements. [PDF]

Cancer Biol Med
Li J, Jiang Z.
europepmc   +1 more source